Glycosylation and related congenital defects (WP4521)

Glycosylation is the most common postranslational modification. Defects in this pathway lead to autosomal recessive disorders, called Congenital disorders of glycosylation (CDG). Up to date about 50 CDGs have been identified and more are expected to be discovered. This category of metabolic disorders can be divided into four basic groups depending on where the glycosylation process occurs on the molecule. The depicts pathway depicts the group of N-glycosylation. Generally, N-glycosylation processes spread over three cellular compartments - cytosol, endoplasmic reticulum and Golgi apparatus. The associated mortality rate in combination with the limited treatment options for CDG, points out the relevance for further investigations of this pathway. Disorders resulting from an enzyme defect are highlighted in pink. This pathway was inspired by Chapter 30 of the book of Blau (ISBN 3642403360 (978-3642403361)).
last edited

Authors

EviSchoenmaker, DeSl, BrittPieters, L Dupuis, IreneHemel, Egonw, Fehrhart, MaintBot, and Finterly

Cited In

Organism

Homo sapiens

Communities

Inborn Errors of Metabolism (IEM) Pathways Rare Diseases

Annotations

Disease Ontology: congenital disorder of glycosylation inherited metabolic disorder autosomal recessive disease

Pathway Ontology: N-acetylglucosamine, N-acetylmannosamine and N-acetylneuraminic acid dissimilation pathway altered carbohydrate metabolic pathway disease pathway

Participants

Label Type Compact Identifier
30.38 Protein uniprot:Q9UPQ8
ALG13 Protein uniprot:Q9NP73
dolichyl phosphate Metabolite chebi:57683
UDP Metabolite chebi:58223
beta-D-glucose Metabolite chebi:15903
DPAGT1 Protein uniprot:Q9H3H5
UDP-N-acetylalpha-D-glucosamine Metabolite chebi:57705
GlcNAc-PP-Dol Metabolite chebi:58427
dolichyl beta-D-mannosyl phosphate Metabolite chebi:58211
Dolichyl phosphate Metabolite chebi:57683
GMPPB Protein uniprot:Q9Y5P6
GDP Metabolite chebi:58189
30.34 Protein uniprot:P15291
Man5-GlcNac2-PP-Dol Metabolite chebi:132516
DPM2 Protein uniprot:O94777
Man8-GlcNac2-PP-Dol Metabolite chebi:132519
Man7-GlcNac2-PP-Dol Metabolite chebi:132517
Man6-GlcNac2-PP-Dol Metabolite None
Man9-GlcNac2-PP-Dol Metabolite chebi:132520
Glc3Man9-GlcNac2-PP-Dol Metabolite None
Glc2Man9-GlcNac2-PP-Dol Metabolite chebi:132522
GlcMan9-GlcNac2-PP-Dol Metabolite chebi:132521
Glc2Man9-GlcNac2-Prot Metabolite chebi:59082
Glc3Man9-GlcNac2-Prot Metabolite chebi:132537
Man3-GlcNac4-Prot Metabolite chebi:60615
Man3-GlcNac3-Prot Metabolite chebi:60615
Sia2Gal2Man3-GlcNac4-Prot Metabolite None
Gal2Man3-GlcNac4-Prot Metabolite None
SiaGalMan3-GlcNac3-Prot Metabolite None
GDP-mannose Metabolite chebi:57527
Dol-P-Man Metabolite chebi:58211
Mannose 6-Phosphate Metabolite chebi:58735
Mannose 1-phosphate Metabolite chebi:58409
Fructose 6-phosphate Metabolite chebi:61527
30.13 Protein uniprot:Q10469
30.14 Protein uniprot:Q13724
30.15 Protein uniprot:Q13454
30.16 Protein uniprot:Q9H0U3
30.6 Protein uniprot:Q9BVK2
30.3 Protein uniprot:Q9Y672
30.10 Protein uniprot:Q9H6U8
30.5 Protein uniprot:Q9BV10
30.10 Protein uniprot:Q9H6U8
30.33 Protein uniprot:O75352
30.4 Protein uniprot:Q92685
30.2 Protein uniprot:P34949
30.1 Protein uniprot:O15305
30.31 Protein uniprot:O60762
30.32 Protein uniprot:Q9P2X0
Man5GIcNAc2-PP-Dol Metabolite chebi:132515
Dolichol phosphate Metabolite chebi:57683
Dolichol-PP Metabolite chebi:15750
30.39 Protein uniprot:Q9H8P0
30.9 Protein uniprot:Q9BT22
30.8 Protein uniprot:Q9H3H5
30.11 Protein uniprot:Q2TAA5
Man3GIcNAc2-PP-Dol Metabolite chebi:132511
Man4GIcNAc2-PP-Dol Metabolite None
Dolichol Metabolite chebi:16091
Polyprenol Metabolite chebi:67132
Man2GIcNAc2PP-Dol Metabolite chebi:132510
Mevalonate Metabolite chebi:17710
ManGlcNAc2-PP-Dol Metabolite chebi:58472
30.7 Protein uniprot:Q9H553
GlcNAc2-PP-Dol Metabolite chebi:57269
dolichyl phosphate Metabolite chebi:57683
dolichyl beta-D-mannosyl phosphate Metabolite chebi:58211
ALG14 Protein ncbigene:199857

References

  1. Dick HM, Strelioff MG, McMurchy KA. Pitfalls in early diagnosis of oral epidermoid carcinoma. J Can Dent Assoc (Tor). 1970 Apr;36(4):151–4. PubMed Europe PMC Scholia
  2. Schachter H, Narasimhan S, Gleeson P, Vella G. Glycosyltransferases involved in elongation of N-glycosidically linked oligosaccharides of the complex or N-acetyllactosamine type. Methods Enzymol. 1983;98:98–134. PubMed Europe PMC Scholia
  3. Tan J, D’Agostaro AF, Bendiak B, Reck F, Sarkar M, Squire JA, et al. The human UDP-N-acetylglucosamine: alpha-6-D-mannoside-beta-1,2- N-acetylglucosaminyltransferase II gene (MGAT2). Cloning of genomic DNA, localization to chromosome 14q21, expression in insect cells and purification of the recombinant protein. Eur J Biochem. 1995 Jul 15;231(2):317–28. PubMed Europe PMC Scholia
  4. Stagljar I, te Heesen S, Aebi M. New phenotype of mutations deficient in glucosylation of the lipid-linked oligosaccharide: cloning of the ALG8 locus. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5977–81. PubMed Europe PMC Scholia
  5. Tan J, Dunn J, Jaeken J, Schachter H. Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. Am J Hum Genet. 1996 Oct;59(4):810–7. PubMed Europe PMC Scholia
  6. Niehues R, Hasilik M, Alton G, Körner C, Schiebe-Sukumar M, Koch HG, et al. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest. 1998 Apr 1;101(7):1414–20. PubMed Europe PMC Scholia
  7. Matthijs G, Schollen E, Heykants L, Grünewald S. Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia). Mol Genet Metab. 1999 Oct;68(2):220–6. PubMed Europe PMC Scholia
  8. Körner C, Knauer R, Stephani U, Marquardt T, Lehle L, von Figura K. Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase. EMBO J. 1999 Dec 1;18(23):6816–22. PubMed Europe PMC Scholia
  9. De Praeter CM, Gerwig GJ, Bause E, Nuytinck LK, Vliegenthart JF, Breuer W, et al. A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. Am J Hum Genet. 2000 Jun;66(6):1744–56. PubMed Europe PMC Scholia
  10. Maeda Y, Tanaka S, Hino J, Kangawa K, Kinoshita T. Human dolichol-phosphate-mannose synthase consists of three subunits, DPM1, DPM2 and DPM3. EMBO J. 2000 Jun 1;19(11):2475–82. PubMed Europe PMC Scholia
  11. Makridakis NM, di Salle E, Reichardt JK. Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II. Pharmacogenetics. 2000 Jul;10(5):407–13. PubMed Europe PMC Scholia
  12. Watanabe R, Murakami Y, Marmor MD, Inoue N, Maeda Y, Hino J, et al. Initial enzyme for glycosylphosphatidylinositol biosynthesis requires PIG-P and is regulated by DPM2. EMBO J. 2000 Aug 15;19(16):4402–11. PubMed Europe PMC Scholia
  13. Schollen E, Dorland L, de Koning TJ, Van Diggelen OP, Huijmans JG, Marquardt T, et al. Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib). Hum Mutat. 2000 Sep;16(3):247–52. PubMed Europe PMC Scholia
  14. Matthijs G, Schollen E, Bjursell C, Erlandson A, Freeze H, Imtiaz F, et al. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia). Hum Mutat. 2000 Nov;16(5):386–94. PubMed Europe PMC Scholia
  15. Cormier-Daire V, Amiel J, Vuillaumier-Barrot S, Tan J, Durand G, Munnich A, et al. Congenital disorders of glycosylation IIa cause growth retardation, mental retardation, and facial dysmorphism. J Med Genet. 2000 Nov;37(11):875–7. PubMed Europe PMC Scholia
  16. Kranz C, Denecke J, Lehrman MA, Ray S, Kienz P, Kreissel G, et al. A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If). J Clin Invest. 2001 Dec;108(11):1613–9. PubMed Europe PMC Scholia
  17. Hansske B, Thiel C, Lübke T, Hasilik M, Höning S, Peters V, et al. Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. J Clin Invest. 2002 Mar;109(6):725–33. PubMed Europe PMC Scholia
  18. Grubenmann CE, Frank CG, Kjaergaard S, Berger EG, Aebi M, Hennet T. ALG12 mannosyltransferase defect in congenital disorder of glycosylation type lg. Hum Mol Genet. 2002 Sep 15;11(19):2331–9. PubMed Europe PMC Scholia
  19. Chantret I, Dancourt J, Dupré T, Delenda C, Bucher S, Vuillaumier-Barrot S, et al. A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation. J Biol Chem. 2003 Mar 14;278(11):9962–71. PubMed Europe PMC Scholia
  20. Thiel C, Schwarz M, Peng J, Grzmil M, Hasilik M, Braulke T, et al. A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. J Biol Chem. 2003 Jun 20;278(25):22498–505. PubMed Europe PMC Scholia
  21. Wu X, Rush JS, Karaoglu D, Krasnewich D, Lubinsky MS, Waechter CJ, et al. Deficiency of UDP-GlcNAc:Dolichol Phosphate N-Acetylglucosamine-1 Phosphate Transferase (DPAGT1) causes a novel congenital disorder of Glycosylation Type Ij. Hum Mutat. 2003 Aug;22(2):144–50. PubMed Europe PMC Scholia
  22. Kelleher DJ, Karaoglu D, Mandon EC, Gilmore R. Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties. Mol Cell. 2003 Jul;12(1):101–11. PubMed Europe PMC Scholia
  23. Schwarz M, Thiel C, Lübbehusen J, Dorland B, de Koning T, von Figura K, et al. Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik. Am J Hum Genet. 2004 Mar;74(3):472–81. PubMed Europe PMC Scholia
  24. Kranz C, Denecke J, Lehle L, Sohlbach K, Jeske S, Meinhardt F, et al. Congenital disorder of glycosylation type Ik (CDG-Ik): a defect of mannosyltransferase I. Am J Hum Genet. 2004 Mar;74(3):545–51. PubMed Europe PMC Scholia
  25. Frank CG, Grubenmann CE, Eyaid W, Berger EG, Aebi M, Hennet T. Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL. Am J Hum Genet. 2004 Jul;75(1):146–50. PubMed Europe PMC Scholia
  26. Parentini I, Cavallini G, Donati A, Gori Z, Bergamini E. Accumulation of dolichol in older tissues satisfies the proposed criteria to be qualified a biomarker of aging. J Gerontol A Biol Sci Med Sci. 2005 Jan;60(1):39–43. PubMed Europe PMC Scholia
  27. Weinstein M, Schollen E, Matthijs G, Neupert C, Hennet T, Grubenmann CE, et al. CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features. Am J Med Genet A. 2005 Jul 15;136(2):194–7. PubMed Europe PMC Scholia
  28. Frank CG, Aebi M. ALG9 mannosyltransferase is involved in two different steps of lipid-linked oligosaccharide biosynthesis. Glycobiology. 2005 Nov;15(11):1156–63. PubMed Europe PMC Scholia
  29. Gao X-D, Tachikawa H, Sato T, Jigami Y, Dean N. Alg14 recruits Alg13 to the cytoplasmic face of the endoplasmic reticulum to form a novel bipartite UDP-N-acetylglucosamine transferase required for the second step of N-linked glycosylation. J Biol Chem. 2005 Oct 28;280(43):36254–62. PubMed Europe PMC Scholia
  30. O’Reilly MK, Zhang G, Imperiali B. In vitro evidence for the dual function of Alg2 and Alg11: essential mannosyltransferases in N-linked glycoprotein biosynthesis. Biochemistry. 2006 Aug 8;45(31):9593–603. PubMed Europe PMC Scholia
  31. Quelhas D, Quental R, Vilarinho L, Amorim A, Azevedo L. Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2. Ann Hum Genet. 2007 May;71(Pt 3):348–53. PubMed Europe PMC Scholia
  32. Kranz C, Jungeblut C, Denecke J, Erlekotte A, Sohlbach C, Debus V, et al. A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy. Am J Hum Genet. 2007 Mar;80(3):433–40. PubMed Europe PMC Scholia
  33. Uemura M, Tamura K, Chung S, Honma S, Okuyama A, Nakamura Y, et al. Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer. Cancer Sci. 2008 Jan;99(1):81–6. PubMed Europe PMC Scholia
  34. Garshasbi M, Hadavi V, Habibi H, Kahrizi K, Kariminejad R, Behjati F, et al. A defect in the TUSC3 gene is associated with autosomal recessive mental retardation. Am J Hum Genet. 2008 May;82(5):1158–64. PubMed Europe PMC Scholia
  35. Molinari F, Foulquier F, Tarpey PS, Morelle W, Boissel S, Teague J, et al. Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. Am J Hum Genet. 2008 May;82(5):1150–7. PubMed Europe PMC Scholia
  36. Lefeber DJ, Schönberger J, Morava E, Guillard M, Huyben KM, Verrijp K, et al. Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies. Am J Hum Genet. 2009 Jul;85(1):76–86. PubMed Europe PMC Scholia
  37. Rind N, Schmeiser V, Thiel C, Absmanner B, Lübbehusen J, Hocks J, et al. A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip. Hum Mol Genet. 2010 Apr 15;19(8):1413–24. PubMed Europe PMC Scholia
  38. Cantagrel V, Lefeber DJ, Ng BG, Guan Z, Silhavy JL, Bielas SL, et al. SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell. 2010 Jul 23;142(2):203–17. PubMed Europe PMC Scholia
  39. Miller BS, Freeze HH, Hoffmann GF, Sarafoglou K. Pubertal development in ALG6 deficiency (congenital disorder of glycosylation type Ic). Mol Genet Metab. 2011 May;103(1):101–3. PubMed Europe PMC Scholia
  40. Würde AE, Reunert J, Rust S, Hertzberg C, Haverkämper S, Nürnberg G, et al. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease. Mol Genet Metab. 2012 Apr;105(4):634–41. PubMed Europe PMC Scholia
  41. Piton A, Redin C, Mandel J-L. XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing. Am J Hum Genet. 2013 Aug 8;93(2):368–83. PubMed Europe PMC Scholia
  42. Mohorko E, Owen RL, Malojčić G, Brozzo MS, Aebi M, Glockshuber R. Structural basis of substrate specificity of human oligosaccharyl transferase subunit N33/Tusc3 and its role in regulating protein N-glycosylation. Structure. 2014 Apr 8;22(4):590–601. PubMed Europe PMC Scholia
  43. Buczkowska A, Swiezewska E, Lefeber DJ. Genetic defects in dolichol metabolism. J Inherit Metab Dis. 2015 Jan;38(1):157–69. PubMed Europe PMC Scholia
  44. Rush ET, Baker CV, Rizzo WB. Dolichol kinase deficiency (DOLK-CDG): Two new cases and expansion of phenotype. Am J Med Genet A. 2017 Sep;173(9):2428–34. PubMed Europe PMC Scholia
  45. Sagami H, Swiezewska E, Shidoji Y. The history and recent advances in research of polyprenol and its derivatives. Biosci Biotechnol Biochem. 2018 Jun;82(6):947–55. PubMed Europe PMC Scholia
  46. Yoo J, Mashalidis EH, Kuk ACY, Yamamoto K, Kaeser B, Ichikawa S, et al. GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation. Nat Struct Mol Biol. 2018 Mar;25(3):217–24. PubMed Europe PMC Scholia
  47. Kadirvelraj R, Yang J-Y, Sanders JH, Liu L, Ramiah A, Prabhakar PK, et al. Human N-acetylglucosaminyltransferase II substrate recognition uses a modular architecture that includes a convergent exosite. Proc Natl Acad Sci U S A. 2018 May 1;115(18):4637–42. PubMed Europe PMC Scholia
  48. Rodríguez Cruz PM, Palace J, Beeson D. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes. Int J Mol Sci. 2018 Jun 5;19(6):1677. PubMed Europe PMC Scholia
  49. PubMed Europe PMC Scholia